These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1771413)

  • 1. Report on a discussion forum: "Medical and surgical application of recombinant hirudin".
    Walenga JM; Markwardt F; Breddin K; Fareed J
    Semin Thromb Hemost; 1991 Apr; 17(2):150-6. PubMed ID: 1771413
    [No Abstract]   [Full Text] [Related]  

  • 2. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comeback of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications and clinical application of thrombosis prophylaxis. I].
    Mittelkötter U; Reith HB; Thiede A
    Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
    Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
    Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
    Walenga JM; Pifarre R; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1989 Jul; 15(3):316-33. PubMed ID: 2688104
    [No Abstract]   [Full Text] [Related]  

  • 7. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hirudin is a heparin alternative in cardiac surgery.
    Riess FC; Bleese N; Kormann J; Pötzsch B; Madlener K; Müller-Berghaus G; Greinacher A
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):538-9. PubMed ID: 9188012
    [No Abstract]   [Full Text] [Related]  

  • 9. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complex prevention of thrombotic complications in patients with colorectal cancer during different stages of surgical treatment].
    Mal'kov OA; Dolgikh VT; Lukach VN
    Anesteziol Reanimatol; 2001; (5):52-4. PubMed ID: 11757303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hopes, joys and disappointments of surgeons in connection with the development of the blood coagulation problem].
    Filatov AN
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):3-10. PubMed ID: 5397112
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant hirudin--initial observations in reconstructive microsurgery.
    Narayanan K; Walenga JM; Liang MD; Fareed J
    Haemostasis; 1991; 21 Suppl 1():168-71. PubMed ID: 1894192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and therapeutic problems in thromboembolic complications in the surgical patient].
    Magrini M
    Acta Anaesthesiol; 1968; 19():Suppl 7:173+. PubMed ID: 5757484
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical and pharmacological principles of antithrombotic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):293-312. PubMed ID: 63418
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis and coagulation: operative management of the anticoagulated patient.
    Owens CD; Belkin M
    Surg Clin North Am; 2005 Dec; 85(6):1179-89, x. PubMed ID: 16326201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of recombinant hirudin: some practical considerations.
    Fareed J; Walenga JM; Hoppensteadt D; Iyer L; Pifarre R
    Semin Thromb Hemost; 1991 Apr; 17(2):137-44. PubMed ID: 1771411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.